Navigation Links
Landmark Patents Issued for ViewRay Technology
Date:5/18/2011

CLEVELAND, May 18, 2011 /PRNewswire/ -- The core technology of ViewRay™, Inc., a unique combination of magnetic resonance imaging (MRI) and radiotherapy technologies, has been issued landmark patents in the United States and Europe. ViewRay, a privately held medical device company, holds the exclusive worldwide license for the technology from the University of Florida. The cancer treatment technology was invented by company founder James F. Dempsey, PhD, while he was a member of the radiation oncology faculty at the University of Florida.

The patented technology is key to ViewRay's new radiation therapy system, which is being designed to capture soft-tissue images continuously during treatment. "The technology is intended to enable clinicians to see precisely where the radiation is being delivered, as it's being delivered," said Dempsey, now ViewRay's chief scientific officer. "Our goal is to allow clinicians to know, to control, and to optimize the dose to the patient." Broadly covering both the medical device and the method of implementation, the patents acknowledge the unique combination of simultaneous MRI and radioisotope irradiation.

The University of Florida encouraged Dempsey to bring his invention to the marketplace, where it could begin to benefit cancer patients, and ViewRay was formed. The ViewRay System, now in the late stages of development, is currently available only as a non-human use research system. The company is working to secure FDA clearance for commercial distribution of the system for clinical use. "These are landmark patents," said David L. Day, director of the University of Florida Office of Technology Licensing. "We believe they are important pieces of intellectual property that can provide significant competitive advantages in the radiation therapy industry."

About ViewRay

ViewRay, Inc., of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy techn
'/>"/>

SOURCE ViewRay, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Key Presentations Announced for Landmark Future of Biosimilars Event Co-Sponsored by DIA and FDLI, Co-Chaired by Merck and PAREXEL
2. Data From Landmark Clinical Trial of Abbotts MitraClip® System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment
3. Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine
4. Landmark National Survey Conducted by Harris Interactive® Sheds Light on Hidden Problem of Heavy Monthly Periods
5. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
6. US HIFU to Fund Landmark Investigation of Focal Therapy for Prostate Cancer
7. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
8. Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R)) Combination Therapy Reduces Early Breast Cancer Recurrence
9. ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
10. Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet
11. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... de mayo de 2015 Dipexium ... compañía farmacéutica de fase tardía centrada en ... cream 0.8%), y colaboradores de investigación clínica, ... destacando el diseño innovador de los ensayos ... que evalúan Locilex®, su nuevo péptido de ...
(Date:5/22/2015)... HILL, N.C. , May 22, 2015 /PRNewswire/ ... critical to pharmaceutical brand recognition and success. ... LLC conducted a study to provide pharmaceutical and ... of investment (FTEs and budget) that are being ... Pharmaceutical and biotech marketing managers can utilize this ...
(Date:5/22/2015)... 22, 2015 The Assistance Fund announces the ... provides financial assistance for copay to individuals diagnosed with ... the addition of the Melanoma Copay Assistance Program to ... , executive director. "With each additional program we are ... world where no one is denied access to medications ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2The Assistance Fund Adds Melanoma Assistance Program 2
... Life Length, the world,s leading telomere testing and services ... have joined its Scientific Advisory Board ("SAB"). ... delighted to welcome these world-renowned telomere and telomerase experts ... global leadership.  Dr Chang is especially well known for ...
... Colo., March 6, 2012   Heska Corporation (NASDAQ: ... veterinary diagnostic and other specialty veterinary products , today ... of best practices research, tools and metrics for patent ... again ranked Heska,s Science Strength in the top 50 ...
Cached Medicine Technology:Drs Sandy Chang and Kathleen Collins Join LIFE LENGTH®'s Scientific Advisory Board 2The Patent Board Ranks Heska's Science Strength in Biotechnology Industry Top 50 2The Patent Board Ranks Heska's Science Strength in Biotechnology Industry Top 50 3
(Date:5/23/2015)... (PRWEB) May 23, 2015 On May 16, ... MuckFest. The event was a 5k mud obstacle run that ... than 2 million people worldwide, and the reason we participated ... said Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred percent ... Sclerosis Society.” , The event was not only attended by ...
(Date:5/23/2015)... Add High-Quality prismatic refractions into footage using ProFlare ... simple as dragging and dropping footage into the FCPX timeline ... , Including over 80 stunning flares, ProFlare 5K Prism ... the ultimate bundle for adding prismatic refractions to any video. ... movie files designed for Final Cut Pro X, but are ...
(Date:5/22/2015)... May 22, 2015 The American College ... events in June. They will hold a webinar on ... a two-day class on Classical Chinese Medicine. , Webinar ... Dr. Steve Given, the Dean of Clinical Education, will ... new First Professional Doctorate program. ACTCM is currently developing ...
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health Limited ... brand Nature’s Way, Marc St-Onge has affirmed his commitment ... is an integral part of the agreement with Nature’s ... further develop Ascenta Skin into a leading player in ... breakthrough, anti-aging skincare supplement featuring 6 active ingredients including ...
(Date:5/22/2015)... “It’s like learning an new ... Vice President of Clinical Operations/Education and Training at ... impacts how care is coded and reimbursed.” , ... care reimbursement, operations and compliance consulting, as well ... launches a new series of day-long seminars on ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:ACTCM Announces Upcoming June Events 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3
... of Medicine Department of Ophthalmology and Visual Sciences has ... awards that could total up to $1 million by ... the most grants awarded in a single year to ... In that time, the program received $2,712,500 from RPB, ...
... Study Shows Long-term Influence of Family ConflictBOSTON, March 9 ... lasting impact on an individual,s mental health and functioning ... the March edition of The Journal of the ... The longitudinal study, led by Simmons School of Social ...
... Teikoku Pharma USA Inc., the international specialty pharmaceutical ... worldwide (excluding Japan) licensing agreement with Eisai Co., ... formulation of donepezil, a leading compound for the ... transdermal formulation is a once-a-week patch that continuously ...
... electronically and efficiently manage and document their control ... Omnicell, Inc. (Nasdaq: OMCL ) a ... facilities, today introduced its Omnicell Tissue Center solution, ... with the latest release of Omnicell OptiFlex(TM) 10.0 ...
... Multiple Sclerosis Society is a driving force in creating a ... Society continues to seek ways to prevent, slow the progression ... is by supporting scientifically meritorious medical research, including research using ... state and local laws and with adherence to the strictest ...
... 9 Beckman Coulter, Inc. (NYSE: BEC ), a ... innovate complex biomedical testing, announced today that Charlie Slacik, Beckman Coulter,s ... following conferences:, , ... 2009 at 2:00 p.m. (ET). , , ...
Cached Medicine News:Health News:Case Western Reserve awarded nearly $1 million from Research to Prevent Blindness Foundation 2Health News:A Lesson for Parents: Arguing in Front of Your Teens Has Lasting Impact, Researchers Find 2Health News:Teikoku Pharma USA and Eisai Co., Ltd. Announce Licensing Agreement for a New 7-Day Transdermal Formulation of Donepezil. 2Health News:Omnicell Unveils Tissue Center Solution - Industry's First Integrated Tissue Tracking and Compliance System 2Health News:Omnicell Unveils Tissue Center Solution - Industry's First Integrated Tissue Tracking and Compliance System 3Health News:National Multiple Sclerosis Society Commends President Obama's Initial Steps in Removing the Bans on Embryonic Stem Cell Research 2Health News:Beckman Coulter to Present at Upcoming Healthcare Conferences 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: